To better address the specificity of the synergy between TKIs and GSIs, we generated isogenic clones carrying the FLT3/ITD mutation in the SKM-1 leukemia cell line, with a 21-bp ITD fragment knocked in using the CRISPR/Cas9 system (Supplemental Fig. S3a). Here, FLT3 is linked to leukemia.